Synopsis
Synopsis
0
USDMF
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Bl S 640
2. Bl S640
3. Bl-s 640
4. Bl-s640
5. Bls 640
6. Bls640
7. S 640 P
8. S 640-p
9. S 640p
10. S-640p
11. S640p
12. Sk And F 60771
13. Sk And F-60771
14. Sk And F60771
15. Skf 60771
16. Skf-60771
17. Skf60771
1. 51627-14-6
2. Bl-s640
3. Cefatrizinum
4. Antibiotic Bl-s 640
5. Bls 640
6. Bl-s 640
7. Skf 60771
8. S-640p
9. Cephatriazine
10. (6r,7r)-7-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-(2h-triazol-4-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
11. J01db07
12. 8p4w949t8k
13. Cefatrizine (usan)
14. Ncgc00185755-01
15. S 640p
16. Cefatrizine [usan]
17. (6r,7r)-7-((r)-2-amino-2-(p-hydroxyphenyl)acetamido)-8-oxo-3-((v-triazol-4-ylthio)methyl)-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid
18. Cefatrizino
19. Orosporina
20. Cefatrix
21. Cepticol
22. Cetrazil
23. Latocef
24. Trizina
25. Bricef
26. (6r,7r)-3-(((1h-1,2,3-triazol-5-yl)thio)methyl)-7-((r)-2-amino-2-(4-hydroxyphenyl)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
27. Cefatrizinum [inn-latin]
28. Cefatrizino [inn-spanish]
29. Cefatrizina
30. Unii-8p4w949t8k
31. Cefatrizine [usan:inn:ban]
32. T-amyl
33. Cefathiamidine,(s)
34. Einecs 257-324-2
35. Cefatrizine [mi]
36. Cefatrizine [inn]
37. Cefatrizine [jan]
38. Dsstox_cid_2752
39. Cefatrizine [mart.]
40. Dsstox_rid_76716
41. Dsstox_gsid_22752
42. Schembl49503
43. Cefatrizine [who-dd]
44. Chembl1095284
45. Dtxsid7022752
46. Gtpl12204
47. Chebi:131730
48. Zinc3830404
49. Tox21_113376
50. Db13266
51. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-4-ylthio)methyl)-, (6r-(6alpha,7beta(r*)))-
52. Cas-51627-14-6
53. Hy-123024
54. Cefatrizine Propylene Glycolate [jan]
55. Cs-0079891
56. D02406
57. 627c146
58. A828691
59. Q3009981
60. (6r,7r)-3-(acetoxymethyl)-7-(2-((e)-n,n'-diisopropylcarbamimidoylthio)acetamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
61. (6r,7r)-7-[[(2r)-2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-8-oxo-3-[(2h-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
62. (6r,7r)-7-[[(2r)-2-azanyl-2-(4-hydroxyphenyl)ethanoyl]amino]-8-oxidanylidene-3-(2h-1,2,3-triazol-4-ylsulfanylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
63. (6r,7r)-7-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1h-1,2,3-triazol-4-ylsulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
64. (6r,7r)-7-{[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-8-oxo-3-[(1h-1,2,3-triazol-4-ylthio)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid
65. (7r)-7-(alpha-d-4-hydroxyphenylglycylamino)-3-(1h-1,2,3-triazol-4-ylthiomethyl)-3-cephem-4-carboxylic Acid
66. 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic Acid, 7-((amino(4-hydroxyphenyl)acetyl)amino)-8-oxo-3-((1h-1,2,3-triazol-4-ylthio)methyl)-, (6r-(6.alpha.,7.beta.(r*)))-
| Molecular Weight | 462.5 g/mol |
|---|---|
| Molecular Formula | C18H18N6O5S2 |
| XLogP3 | -2.3 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 462.07801004 g/mol |
| Monoisotopic Mass | 462.07801004 g/mol |
| Topological Polar Surface Area | 225 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 775 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
J - Antiinfectives for systemic use
J01 - Antibacterials for systemic use
J01D - Other beta-lactam antibacterials
J01DB - First-generation cephalosporins
J01DB07 - Cefatrizine
ABOUT THIS PAGE
A Cefatrizine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cefatrizine, including repackagers and relabelers. The FDA regulates Cefatrizine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cefatrizine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cefatrizine supplier is an individual or a company that provides Cefatrizine active pharmaceutical ingredient (API) or Cefatrizine finished formulations upon request. The Cefatrizine suppliers may include Cefatrizine API manufacturers, exporters, distributors and traders.
click here to find a list of Cefatrizine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cefatrizine Drug Master File in Korea (Cefatrizine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cefatrizine. The MFDS reviews the Cefatrizine KDMF as part of the drug registration process and uses the information provided in the Cefatrizine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cefatrizine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cefatrizine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cefatrizine suppliers with KDMF on PharmaCompass.
A Cefatrizine CEP of the European Pharmacopoeia monograph is often referred to as a Cefatrizine Certificate of Suitability (COS). The purpose of a Cefatrizine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cefatrizine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cefatrizine to their clients by showing that a Cefatrizine CEP has been issued for it. The manufacturer submits a Cefatrizine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cefatrizine CEP holder for the record. Additionally, the data presented in the Cefatrizine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cefatrizine DMF.
A Cefatrizine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cefatrizine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cefatrizine suppliers with CEP (COS) on PharmaCompass.
Cefatrizine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cefatrizine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cefatrizine GMP manufacturer or Cefatrizine GMP API supplier for your needs.
A Cefatrizine CoA (Certificate of Analysis) is a formal document that attests to Cefatrizine's compliance with Cefatrizine specifications and serves as a tool for batch-level quality control.
Cefatrizine CoA mostly includes findings from lab analyses of a specific batch. For each Cefatrizine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cefatrizine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cefatrizine EP), Cefatrizine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cefatrizine USP).
LOOKING FOR A SUPPLIER?
